Scheme will be first New Hospital Programme facility in East of England
Laing O鈥橰ourke has been picked as the preferred contractor to build a new specialist cancer research hospital in Cambridge.
The company has been appointed under a pre-construction services contract, which will combine an NHS clinical space with three cancer research institutes.
It comes after the 26,300 sq m facility鈥檚 outline business case was approved by NHS England, the Department of Health and Social Care and HM Treasury.
The seven-storey hospital will be based at the Cambridge Biomedical Campus and will be the first hospital delivered in the East of England as part of the government鈥檚 New Hospital Programme.
Work is expected to cost around 拢220m with the job designed by specialist architect NBBJ and Aecom carrying out cost management work.
>> Read more: Government unveils 拢20bn New Hospital Programme relaunch
>> Read more: Rebooting the New Hospital Programme: Is this the solution to the NHS backlog?
O鈥橰ourke鈥檚 healthcare sector lead Rory Pollock said it would 鈥渕aximise the use of modern
methods of construction鈥� to improve programme delivery and cost certainty.
O鈥橰ourke was appointed after a competitive process using the Crown Commercial Service鈥檚 Construction Works and Associated Services 2 framework.
A full planning application for Cambridge Cancer Research Hospital was submitted to Cambridge City Council in January and a decision is expected later this year.
Work to build the new hospital is set to begin in 2024.
Laing O鈥橰ourke has also been lined up to build a huge cancer research facility in Oxford designed by Foster & Partners and bankrolled by American billionaire Lawrence J.Ellison, the world鈥檚 seventh richest person.
Proposals for a UK branch of the Los Angeles-based Ellison Institute for Transformative Medicine consist of a complex of buildings spread across two sites and linked by a 250m-long elevated timber walkway. The scheme was approved in the spring.
No comments yet